Cuiling Zhong
Molecular Biology · 2007–2009
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 40 citations into it
- Cancer Research — 25 citations into it
Whom Cuiling Zhong trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Cuiling Zhong's perspective
Ordered by how strongly the researchers Cuiling Zhong trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular mechanisms of drug resistance (Journal of Pathology)
- Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. (Cancer Research)
- Vascular endothelial growth factor: basic science and clinical progress. (Endocrine reviews)
- Tumor angiogenesis (Advances in Cancer Research)
- VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. (Cell)
- Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
- TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia (Science)
- Molecular characterization of the tumor microenvironment in breast cancer. (Cancer Cell)
- Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type (Cell Cycle)
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. (Cancer Cell)
Their papers
- PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. (2009) — 618 citations
- Bv8 regulates myeloid-cell-dependent tumour angiogenesis (2007) — 645 citations
- Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (2007) — 887 citations